Published in Clin Exp Immunol on April 01, 1974
Electrical charge of the antigen determines intraarticular antigen handling and chronicity of arthritis in mice. J Clin Invest (1984) 1.75
Antigen handling in antigen-induced arthritis in mice: an autoradiographic and immunofluorescence study using whole joint sections. Am J Pathol (1982) 1.48
Mechanism of trapping of immune complexes in joint collagenous tissues. Clin Exp Immunol (1975) 1.38
Immune elimination and immune retention: the relationship between antigen retained in the foot and the elicitation of footpad swelling. Immunology (1980) 1.28
The non-passage of mycobacteria from Freund's complete adjuvant granuloma depots to arthritic joints. Br J Exp Pathol (1975) 1.26
Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy. J Biomed Biotechnol (2010) 1.16
Is persisting antigen responsible for the chronicity of experimental allergic arthritis? Ann Rheum Dis (1977) 1.04
Electrical charge of the antigen determines its localization in the mouse knee joint. Deep penetration of cationic BSA in hyaline articular cartilage. Am J Pathol (1985) 1.03
Persistence of antigen in nonarthritic joints. Ann Rheum Dis (1975) 1.03
Cationic Yersinia antigen-induced chronic allergic arthritis in rats. A model for reactive arthritis in humans. J Clin Invest (1991) 1.01
Antigen handling in antigen-induced joint inflammation: kinetics of a second intra-articularly injected dose of antigen in an already established antigen-induced joint inflammation. Immunology (1981) 0.98
Studies on increased vascular permeability in the pathogenesis of lesions of connective tissue diseases: I. Experimental hyperlipidaemia and immune arthropathy. Ann Rheum Dis (1980) 0.88
Binding of immunoglobulins and immune complexes to cartilage derived extracts. Clin Exp Immunol (1983) 0.87
Antigen-induced arthritis: inflammation and antigen handling after two different doses of intra-articularly injected antigen. Immunology (1982) 0.86
Allergic arthritis induced by cationic proteins: role of molecular weight. Immunology (1989) 0.85
Antibody isotypes mediating antigen retention in passively immunized mice. Immunology (1980) 0.83
The specific in vitro antibody-mediated retention of bovine serum albumin by porcine hyaline articular cartilage. Clin Exp Immunol (1983) 0.83
Electrical charge and joint inflammation. Suppression of cationic aBSA-induced arthritis with a competitive polycation. Am J Pathol (1987) 0.81
Intra-articular immunization induces strong systemic immune response in humans. Clin Exp Immunol (1990) 0.79
Fine specificity of serum anticollagen molecules in experimental immune synovitis. Ann Rheum Dis (1985) 0.79
The hydrolysis of rabbit y-globulin and antibodies with crystalline papain. Biochem J (1959) 31.27
Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds. Arch Biochem Biophys (1960) 13.40
High specific activity iodination of gamma-globulin with iodine-131 monochloride. Cancer Res (1960) 5.09
Production of a chronic arthritis with ovalbumin. Its retention in the rabbit knee joint. Ann Rheum Dis (1971) 3.73
Studies on antigen-antibody complexes. I. Elimination of soluble complexes from rabbit circulation. J Exp Med (1971) 3.51
The chronicity of inflammation and its significance in rheumatoid arthritis. Ann Rheum Dis (1968) 3.31
EXPERIMENTAL GLOMERULONEPHRITIS. V. STUDIES ON THE INTERACTION OF NEPHROTOXIC ANTIBODIES WITH TISSUE OF THE RAT. J Exp Med (1965) 2.83
The pathogenesis of chronic inflammation in experimental antigen-induced arthritis. II. Preferential localization of antigen-antibody complexes to collagenous tissues. J Exp Med (1972) 2.74
GROSS CONFORMATION OF RABBIT 7 S GAMMA-IMMUNOGLOBULIN AND ITS PAPAIN-CLEAVED FRAGMENTS. J Biol Chem (1965) 2.21
Quantitation of acute and chronic serum sickness in the rabbit. J Exp Med (1971) 1.74
Molecular composition and sedimentation characteristics of soluble antigen-antibody complexes. Biochemistry (1972) 1.64
Persistence of antigen in rabbit synovial membrane. Br J Exp Pathol (1971) 1.46
RECOMBINATION OF ANTIBODY POLYPEPTIDE CHAINS IN THE PRESENCE OF ANTIGEN. J Exp Med (1964) 1.34
Acute immunologic arthritis in rabbits. J Clin Invest (1972) 1.14
Induction of proliferative synovitis in rabbits by intra-articular injection of immune complexes. Arthritis Rheum (1967) 1.13
COMPARISON OF TWO PRECIPITATING DERIVATIVES OF RABBIT ANTIBODY: FRAGMENT I DIMER AND THE PRODUCT OF PEPSIN DIGESTION. Biochemistry (1965) 1.13
Immunologically induced acute synovitis in rabbits. Studies of immune complexes in synovial fluid. Arthritis Rheum (1973) 0.92
Individual Antigenic Specificity of Isolated Antibodies. Science (1963) 7.27
Saturation of the reticuloendothelial system with soluble immune complexes. J Immunol (1974) 3.65
Studies on antigen-antibody complexes. I. Elimination of soluble complexes from rabbit circulation. J Exp Med (1971) 3.51
Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med (1983) 3.17
The macrophage receptor for IgG: number and affinity of binding sites. J Immunol (1973) 2.91
Role of marrow-derived monocytes and mesangial cells in removal of immune complexes from renal glomeruli. J Exp Med (1979) 2.27
In vitro adherence of soluble immune complexes to macrophages. J Exp Med (1972) 2.26
Immunoglobulins in temporal arteries. An immunofluorescent study. Ann Intern Med (1974) 2.02
The glomerular deposition of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice. Lab Invest (1976) 2.01
Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet (1994) 2.00
The disappearance kinetics of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice. Lab Invest (1976) 1.84
Studies on antigen-antibody complexes. II. Quantification of tissue uptake of soluble complexes in normal and complement-depleted rabbits. J Immunol (1971) 1.77
The molecular basis of self-association of antibodies to IgG (rheumatoid factors) in rheumatoid arthritis. Proc Natl Acad Sci U S A (1974) 1.76
Specificity of recombination of H and L chains from human gamma-G-myeloma proteins. J Exp Med (1965) 1.69
Molecular composition and sedimentation characteristics of soluble antigen-antibody complexes. Biochemistry (1972) 1.64
Effect of cortisone on the disappearance kinetics and tissue localization of soluble immune complexes. J Immunol (1975) 1.62
Human IgM molecules that bind staphylococcal protein A contain VHIII H chains. J Immunol (1989) 1.59
Effect of cationized antibodies in performed immune complexes on deposition and persistence in renal glomeruli. J Exp Med (1982) 1.54
Antibody-agarose immunoadsorbents: complete removal of classes of immunoglobulins from serum. J Immunol (1971) 1.54
The hyperviscosity syndrome in rheumatoid arthritis due to intermediate complexes formed by self-association of IgG-rheumatoid factors. Arthritis Rheum (1975) 1.54
The disappearance kinetics and glomerular deposition of small-latticed soluble immune complexes. Immunology (1982) 1.54
Human IgA and IgG F(ab')2 that bind to staphylococcal protein A belong to the VHIII subgroup. J Immunol (1991) 1.49
Kinetics and mechanisms for removal of circulating single-stranded DNA in mice. J Exp Med (1978) 1.46
Removal of glomerular deposits of immune complexes in mice by administration of excess antigen. Lab Invest (1980) 1.42
Chemotaxigenesis and complement fixation by Listeria monocytogenes cell wall fractions. J Immunol (1977) 1.36
The distribution of antigenic determinants in rat skin collagen. J Exp Med (1971) 1.35
Clearance kinetics and fate of mouse IgA immune complexes prepared with monomeric or dimeric IgA. J Immunol (1983) 1.34
Diagnostic value of antibodies to filaggrin in rheumatoid arthritis. J Rheumatol (1998) 1.32
Clearance of circulating IgA immune complexes is mediated by a specific receptor on Kupffer cells in mice. J Exp Med (1984) 1.31
Pathophysiology of circulating immune complexes. Arthritis Rheum (1982) 1.28
Binding of albumin to gamma-A-myeloma proteins and Waldenström macroglobulins by disulfide bonds. J Immunol (1967) 1.28
The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A. J Exp Med (1993) 1.26
Clearance of circulating DNA-anti-DNA immune complexes in mice. J Exp Med (1982) 1.23
Clearance and tissue uptake of immune complexes in complement-depleted and control mice. Immunology (1981) 1.20
The molecular basis of self-association of IgG-Rheumatoid factors. J Immunol (1975) 1.19
IgG rheumatoid factors and staphylococcal protein A bind to a common molecular site on IgG. J Exp Med (1985) 1.18
Effect of DNA size and strandedness on the in vivo clearance and organ localization of DNA. Clin Exp Immunol (1984) 1.15
Blood clearance kinetics and liver uptake of mononucleosomes in mice. J Immunol (1996) 1.15
Fate of preformed immune complexes in rabbits and rhesus monkeys. J Exp Med (1971) 1.14
Determination of soluble immune complex molar composition and antibody association constants by ammonium sulfate precipitation. J Immunol (1974) 1.14
7S M-globulin in rheumatoid arthritis. Evaluation of its clinical significance. Arthritis Rheum (1971) 1.13
Studies on the antigenic determinants in the self-association of IgG rheumatoid factor. J Exp Med (1981) 1.12
Precipitating antigen-antibody systems are required for the formation of subepithelial electron-dense immune deposits in rat glomeruli. J Exp Med (1983) 1.11
Rearrangement of immune complexes in glomeruli leads to persistence and development of electron-dense deposits. J Exp Med (1983) 1.09
Nonimmunospecific protein-protein interactions of IgG: studies of the binding of IgG to IgG immunoadsorbents. J Immunol (1978) 1.08
Physicochemical and functional relationships of immune complexes. J Invest Dermatol (1980) 1.07
Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. J Clin Invest (1988) 1.07
Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases. Arthritis Rheum (1989) 1.05
Intermediate complexes formed by self-association of IgG-rheumatoid factors. Ann N Y Acad Sci (1975) 1.05
Self-associating IgG rheumatoid factors in MRL/l autoimmune mice. Arthritis Rheum (1984) 1.04
Glomerular localization of preformed immune complexes prepared with anionic antibodies or with cationic antigens. Lab Invest (1984) 1.03
IgG rheumatoid factors and self-association of these antibodies. Clin Rheum Dis (1985) 1.01
Serum sickness secondary to treatment with the murine-human chimeric antibody IDEC-C2B8 (rituximab). Arthritis Rheum (2001) 1.00
Covalent binding of molecules to CNBr-activated agarose: parameters relevant to the activation and coupling reactions. Biochim Biophys Acta (1974) 1.00
Evaluation of immunological specificity of flurescein-conjugated antisera with agarose-antigen sections. Infect Immun (1975) 1.00
Rheumatoid factors from patients with rheumatoid arthritis possess private repertoires of idiotypes. J Immunol (1987) 1.00
Interaction between herpes simplex type 1-induced Fc receptor and human and rabbit immunoglobulin G (IgG) domains. Immunology (1986) 1.00
Steroid myopathy: incidence and detection in a population with asthma. J Allergy Clin Immunol (1985) 0.98
Engineering N-glycosylation pathways in the baculovirus-insect cell system. Curr Opin Biotechnol (1998) 0.98
Evaluation of aggregated IgG in mice as an Fc receptor specific probe of the hepatic mononuclear phagocyte system. Clin Exp Immunol (1982) 0.98
Rheumatoid factors in rheumatoid arthritis. Bull Rheum Dis (1973) 0.98
Effect of preformed immune complexes on the clearance and tissue localization of single-stranded DNA in mice. Clin Exp Immunol (1980) 0.98
Self-associating IgG rheumatoid factors stimulate monocytes to release prostaglandins and mononuclear cell factor that stimulates collagenase and prostaglandin production by synovial cells. Rheumatol Int (1983) 0.97
Mechanisms of tissue deposition of immune complexes. J Rheumatol Suppl (1987) 0.96
Mammalian glycosyltransferase expression allows sialoglycoprotein production by baculovirus-infected insect cells. Protein Expr Purif (2001) 0.96
Autoantibodies to the collagen-like region of C1Q deposit in glomeruli via C1Q in immune deposits. Clin Immunol Immunopathol (1991) 0.96
Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus. Medicine (Baltimore) (1987) 0.96
Antigenic specificities of human monoclonal and polyclonal IgM rheumatoid factors. The C gamma 2-C gamma 3 interface region contains the major determinants. J Immunol (1988) 0.94
The discriminating value of serum lactate dehydrogenase levels in children with malignant neoplasms presenting as joint pain. Arch Pediatr Adolesc Med (1996) 0.94
Removal of glomerular immune complex deposits by excess antigen in chronic mouse model of immune complex disease. Lab Invest (1983) 0.93
Covalently cross-linked immune complexes prepared with multivalent cross-linking antigens. J Immunol (1981) 0.93
Immunologically induced acute synovitis in rabbits. Studies of immune complexes in synovial fluid. Arthritis Rheum (1973) 0.92
Hepatic uptake of small-latticed immune complexes does not alter mononuclear phagocyte system function. Immunology (1983) 0.90
Blood viscosity in Waldenström's macroglobulinemia. Blood (1974) 0.90
Mechanisms of immune deposit formation in renal glomeruli. Springer Semin Immunopathol (1986) 0.89
Human rheumatoid factors bear the internal image of the Fc binding region of staphylococcal protein A. J Exp Med (1987) 0.89
Preparation and characterization of 4-azido-2-nitrophenyl human serum albumin as an antigen for covalent cross-linking of immune complexes. J Immunol (1981) 0.89
Only the initial binding of cationic immune complexes to glomerular anionic sites is mediated by charge-charge interactions. J Immunol (1986) 0.87
Antibody localization in the glomerular basement membrane may precede in situ immune deposit formation in rat glomeruli. J Immunol (1985) 0.87
A method for isolation of mouse glomeruli for quantitation of immune deposits. Kidney Int (1988) 0.87
Identification of the site on IgG Fc for interaction with streptococci of groups A, C and G. Immunology (1987) 0.86
Immune complexes with cationic antibodies deposit in glomeruli more effectively than cationic antibodies alone. J Immunol (1987) 0.86
Interaction between streptococcal IgG Fc receptors and human and rabbit IgG domains. Immunology (1986) 0.85
Monocyte enhancement of mitogen-induced lymphocyte proliferation in a human co-culture system. Cell Immunol (1978) 0.85
A small proportion of cationic antibodies in immune complexes is sufficient to mediate their deposition in glomeruli. J Immunol (1990) 0.85
Hyperviscosity syndrome in multiple myeloma. A reversible, concentration-dependent aggregation of the myeloma protein. Am J Med (1973) 0.85
Selective losses of large immune complexes during density gradient ultracentrifugation and an approach for prevention of these losses. J Immunol Methods (1985) 0.84
Limb pain in childhood. Pediatr Clin North Am (1984) 0.84
Variability in the specific interactions of H and L chains of gamma-G-globulins. Biochemistry (1967) 0.84
Hepatic binding of DNA is mediated by a receptor on nonparenchymal cells. Am J Pathol (1988) 0.84
Human complement activation by self-associated IgG rheumatoid factors. Arthritis Rheum (1982) 0.83
The location of binding sites on C1q for DNA. J Immunol (1990) 0.83
Immune deposits in articular cartilage of patients with rheumatoid arthritis have a granular pattern not seen in osteoarthritis. Rheumatol Int (1990) 0.83
Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum (1977) 0.82
C1q-binding immunoglobulin G in MRL/l mice consists of immune complexes containing antibodies to DNA. Clin Immunol Immunopathol (1995) 0.81
Binding of double-stranded DNA to glomeruli of rats in vivo. Arthritis Rheum (1989) 0.81
Contact with specific surfaces stimulates the production of the second component of complement (C2) in human peripheral blood monocytes via a lymphocyte factor. J Reticuloendothel Soc (1982) 0.81
Clearance kinetics and organ uptake of complement-solubilized immune complexes in mice. Immunology (1987) 0.81
Treatment of rheumatoid arthritis with a tumor necrosis factor receptor-Fc fusion protein. N Engl J Med (1997) 0.80